In a time of increasingly bespoke healthcare, Elizabeth Philp has become a significant voice of innovation, especially in the tech-driven field of compounded pharmacy. As the co-founder and CEO of Roseway Labs, Philp is at the helm of a movement to make tailor-made medications more available, disrupting the conventional one-size-fits-all approach